{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T11:37:37Z","timestamp":1789645057225,"version":"4.0.0"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartandlung.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart & Lung"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.hrtlng.2024.11.012","type":"journal-article","created":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T23:39:32Z","timestamp":1735342772000},"page":"214-222","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Methamphetamine-associated heart failure: Clinical characteristics and outcomes in a safety net population"],"prefix":"10.1016","volume":"70","author":[{"given":"Anjali B.","family":"Thakkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew S.","family":"Durstenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sithu","family":"Win","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla Y.","family":"Hsue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrtlng.2024.11.012_bib0001","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1001\/jamapsychiatry.2020.4321","article-title":"Methamphetamine overdose deaths in the us by sex and race and ethnicity","volume":"78","author":"Han","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.hrtlng.2024.11.012_bib0002","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.3758","article-title":"Evaluation of amphetamine-related hospitalizations and associated clinical outcomes and costs in the United States","volume":"1","author":"Winkelman","year":"2018","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.hrtlng.2024.11.012_bib0003","series-title":"Methamphetamine Toxicity","author":"Richards JR","year":"2020"},{"key":"10.1016\/j.hrtlng.2024.11.012_bib0004","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1161\/ATVBAHA.119.312461","article-title":"Methamphetamine use and cardiovascular disease","volume":"39","author":"Kevil","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.hrtlng.2024.11.012_bib0005","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jacc.2019.12.026","article-title":"Readmission and mortality after hospitalization for myocardial infarction and heart failure","volume":"75","author":"Ko","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrtlng.2024.11.012_bib0006","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s12012-015-9350-y","article-title":"Methamphetamine-associated congestive heart failure: increasing prevalence and relationship of clinical outcomes to continued use or abstinence","volume":"16","author":"Sliman","year":"2016","journal-title":"Cardiovasc Toxicol"},{"key":"10.1016\/j.hrtlng.2024.11.012_bib0007","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.018370","article-title":"Methamphetamine\u2010associated heart Failure hospitalizations across the United States: geographic and social disparities","volume":"10","author":"Dickson","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hrtlng.2024.11.012_bib0008","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.cardfail.2019.10.002","article-title":"Clinical characteristics and outcomes of patients with heart failure and methamphetamine abuse","volume":"26","author":"Thomas","year":"2020","journal-title":"J Card Fail"},{"key":"10.1016\/j.hrtlng.2024.11.012_bib0009","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.amjcard.2019.09.030","article-title":"Comparison of clinical characteristics and outcomes of patients with reversible versus persistent methamphetamine-associated cardiomyopathy","volume":"125","author":"Zhao","year":"2020","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrtlng.2024.11.012_bib0010","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.amjcard.2021.06.001","article-title":"Characteristics of Methamphetamine-associated Cardiomyopathy and the Impact of Methamphetamine Use on Cardiac Dysfunction","volume":"154","author":"Reddy","year":"2021","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrtlng.2024.11.012_bib0011","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1081\/CLT-120026521","article-title":"Crystal methamphetamine-associated cardiomyopathy: tip of the iceberg?","volume":"41","author":"Wijetunga","year":"2003","journal-title":"J Toxicol Clin Toxicol"},{"key":"10.1016\/j.hrtlng.2024.11.012_bib0012","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1016\/j.jacc.2017.08.074","article-title":"Heart Failure with preserved, borderline, and reduced ejection fraction","volume":"70","author":"Shah","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrtlng.2024.11.012_bib0013","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jacc.2017.05.014","article-title":"The cardiovascular effects of cocaine","volume":"70","author":"Havakuk","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrtlng.2024.11.012_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2017.06.014","article-title":"Alcoholic cardiomyopathy: what is known and what is not known","volume":"43","author":"Mirijello","year":"2017","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.hrtlng.2024.11.012_bib0015","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jacc.2019.11.025","article-title":"Marijuana use in patients with cardiovascular disease","volume":"75","author":"DeFilippis","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrtlng.2024.11.012_bib0016","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/MLR.0000000000000492","article-title":"Post-discharge follow-up characteristics associated with 30-day readmission after heart failure hospitalization","volume":"54","author":"Lee","year":"2016","journal-title":"Med Care"}],"container-title":["Heart & Lung"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0147956324002309?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0147956324002309?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T08:51:01Z","timestamp":1762246261000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0147956324002309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":16,"alternative-id":["S0147956324002309"],"URL":"https:\/\/doi.org\/10.1016\/j.hrtlng.2024.11.012","relation":{},"ISSN":["0147-9563"],"issn-type":[{"value":"0147-9563","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Methamphetamine-associated heart failure: Clinical characteristics and outcomes in a safety net population","name":"articletitle","label":"Article Title"},{"value":"Heart & Lung","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrtlng.2024.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}